These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22516263)

  • 1. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
    Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
    Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 3. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
    Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
    Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEIS proteins as partners of the TLX1/HOX11 oncoprotein.
    Milech N; Gottardo NG; Ford J; D'Souza D; Greene WK; Kees UR; Watt PM
    Leuk Res; 2010 Mar; 34(3):358-63. PubMed ID: 19559479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.
    Villarese P; Lours C; Trinquand A; Le Noir S; Belhocine M; Lhermitte L; Cieslak A; Tesio M; Petit A; LeLorch M; Spicuglia S; Ifrah N; Dombret H; Langerak AW; Boissel N; Macintyre E; Asnafi V
    Leukemia; 2018 Jan; 32(1):61-71. PubMed ID: 28592888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.
    Durinck K; Van Loocke W; Van der Meulen J; Van de Walle I; Ongenaert M; Rondou P; Wallaert A; de Bock CE; Van Roy N; Poppe B; Cools J; Soulier J; Taghon T; Speleman F; Van Vlierberghe P
    Leukemia; 2015 Dec; 29(12):2317-27. PubMed ID: 26108691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
    Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
    Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.
    Vanden Bempt M; Demeyer S; Broux M; De Bie J; Bornschein S; Mentens N; Vandepoel R; Geerdens E; Radaelli E; Bornhauser BC; Kulozik AE; Meijerink JP; Bourquin JP; de Bock CE; Cools J
    Cancer Cell; 2018 Aug; 34(2):271-285.e7. PubMed ID: 30107177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
    Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
    Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
    Meijerink JP
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.
    Owens BM; Hawley TS; Spain LM; Kerkel KA; Hawley RG
    Br J Haematol; 2006 Jan; 132(2):216-29. PubMed ID: 16398656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage, cell-type and promoter context-dependent.
    Rice KL; Kees UR; Greene WK
    Biochem Biophys Res Commun; 2008 Mar; 367(3):707-13. PubMed ID: 18073142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
    Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
    Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
    Bergeron J; Clappier E; Radford I; Buzyn A; Millien C; Soler G; Ballerini P; Thomas X; Soulier J; Dombret H; Macintyre EA; Asnafi V
    Blood; 2007 Oct; 110(7):2324-30. PubMed ID: 17609427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.
    Rakowski LA; Lehotzky EA; Chiang MY
    PLoS One; 2011 Feb; 6(2):e16761. PubMed ID: 21326611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.
    De Keersmaecker K
    Haematologica; 2012 Jun; 97(6):795. PubMed ID: 22665526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.